Sotoxen 120 mg (Sotorasib)

Sotoxen 120 mg (Sotorasib)


Generic Name: Sotorasib
Pack Size: 56 Tablets
Manufacture: Everest Pharmaceuticals Ltd


Sotoxane 120 mg (Sotaracib):

Non-small cell lung cancer (NSCLC) with a specific mutation known as KRAS G12C is treated with sotoracib. Also marketed as Sotoxen 120 mg. The revolutionary drug Sotoxane was specially developed for this purpose. Sotoxane acts as an irreversible inhibitor of KRAS protein. Interferes with signaling pathways that promote cancer development. Sotoxane was previously believed to be difficult to target for KRAS mutations, which emphasizes the importance of this customized therapy. Positive results from clinical trials suggest that patients with NSCLC who are KRAS G12C positive may benefit from treatment. Like any medicine, Sotoxane can have side effects. So doctors should regularly supervise their use. Sotoxane is a significant advance in cancer precision medicine and offers hope for those with this particular genetic mutation.

What is Sotoxen and how does it work:

Amgen produced sotorasib, also referred to as AMG-510, which is a KRAS inhibitor made from acrylamide. Adult patients with KRAS G12C-mutant non-small cell lung cancer should be treated. The Sotorasib mutation is present in 13% of solid tumors, 3% of colorectal and appendix cancers, and 3% of non-small cell lung cancers. Sotoxen 120 mg accounts for more than half of all KRAS mutations. Sotorasib interacts with cysteine residues in the KRAS G12C mutation, preventing the protein from being activated. Hepatotoxicity, interstitial lung disease, and other adverse effects are conceivable.

Generic Sotorasib 120 mg

One drug used to treat non-small cell lung cancer (NSCLC) with the KRAS G12C genetic mutation is sotorasib 120 mg. It is a member of the class of medications called as targeted treatment, which slows down or stops the proliferation of cancer cells by blocking the action of the aberrant KRAS protein.

Promising outcomes from clinical trials indicate the treatment’s efficacy in patients with advanced non-small cell lung cancer (NSCLC) who have previously received various therapies and carry the KRAS G12C mutation. For individuals with this specific genetic mutation, sotorasib provides a novel therapeutic option that fills a medical gap in the treatment of lung cancer.

As with any drug, Sotorasib can have adverse effects, such as fatigue, nausea, diarrhea, and abnormal liver enzyme levels. Before beginning treatment, patients should talk through potential risks and benefits with their healthcare professional.

How to order IEB Pharma medicine…?

Ordering our IEB Pharma Medicines is easy. Currently there is no automated ordering system on our website, we offer various options for ordering IEB Pharma Medicines.

WhatsApp: You can send a message by clicking on our WhatsApp button, a customer service representative of ieb Pharma will assist you in placing your order.

Telegram/Messenger/WeChat: If you want to place an order on our Facebook messenger or Telegram or WeChat, then you can easily place an order by clicking on our message option button.

Email: You can message us at [email protected] for details about your order. We answer your call as soon as we can.